Human immunodeficiency virus-related lymphoma: Prognostic factors predictive of survival
✍ Scribed by Bruno Taillan; Georges Garnier; Stéphane Schneider; Alain Pesce; Jean Gabriel Fuzibet; Pierre Dujardin; Alexandra M. Levine
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 239 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The current study evaluated factors influencing survival in patients diagnosed with human immunodeficiency virus (HIV)‐related primary central nervous system lymphoma (PCNSL), with a focus on the effects of therapeutic radiotherapy (RT) and highly active antiretroviral th
## BACKGROUND. The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered to be poor. To the authors' knowledge the impact of highly active antiretroviral therapy, recently introduced in HIV disease case m
## BACKGROUND. The International Prognostic Index (IPI) effectively separates aggressive lymphomas into four groups with significantly different responses to therapy and survival. The authors have applied the IPI to evaluate a series of patients with human immunodeficiency virus (HIV) related lymp
for the Groupe d'Etudes des a standard method, prognostic factors were identified in a training sample and confirmed in a validation sample. The independently significant covariates were Lymphomes de l'Adulte then included in a step-function regression model (3-step) that permitted determi-1 Unite ´
## Background: The prognosis of patients with human immunodeficiency virus (hiv)-related non-hodgkin lymphoma (nhl) is poor. in fact, despite a high complete response (cr) rate, approximately 50% of these patients die from progressive lymphoma. ## Methods: From november 1994 to april 2000, the au